Prescription opioids, intended for post-surgery utilization, often go unused and undisposed, leading to the nonmedical use of opioids that could have harmful consequences.
Prescription opioids, intended for post-surgery utilization, often go unused and undisposed, leading to the nonmedical use of opioids that could have harmful consequences.
A study recently published by JAMA Surgery used MEDLINE, EMBASE, and Cochrane Register of Controlled Trials to search for studies that evaluate opioid oversupply for adults following a surgical procedure. This oversupply, or primary outcome, was categorized as the number of patients with filled but unused opioid prescriptions or unfilled opioid prescriptions.
“Prescriptions may go unfilled for several reasons, including adequate pain control after surgery,” the authors wrote. There are also instances where patients fill the prescription, but do not finish the medication, “leading to a reservoir of pills that can potentially contribute to the nonmedical use of opioids.”
From the database search, the researchers found 6 studies that reported a total of 810 patients who experienced 7 different types of surgical procedures. Among all of the studies considered, 67% to 92% of patients reported not using their opioid prescription; among all opioid tablets obtained by surgical patients, 42% to 71% were unused.
The majority of patients stopped using or did not use opioids once their pain was controlled. However, 16% to 29% of patients had reported adverse effects that were a result of their opioid utilization.
The research also considered the safety of how patients were storing their unused opioids. Of the studies reviewed, 2 evaluated storage safety and found that 73% to 77% of patients reported that they did not store their opioids in locked storage containers. This ultimately can contribute to opioid use by those who were not prescribed the drug originally.
Additionally, all of the observed studies had reported low rates of anticipated or actual disposal, but, no study had reported the use of the FDA recommended disposal method in more than 9% of patients. This, again, demonstrating the lack of prevention for those without a medical need to have access to the drug.
“Postoperative prescription opioids often go unused, unlocked, and undisposed, suggesting an important reservoir of opioids contributing to nonmedical use of these products, which could cause injuries or even deaths,” the authors concluded.
Recognizing Symptoms of Myeloproliferative Neoplasms and Clinical Trial Challenges
October 24th 2024There can be a delay in diagnosis of myeloproliferative neoplasms as the symptoms of the diseases can be variable and common, such as fatigue, migraines, and difficulty concentrating, explained Ruben Mesa, MD, of Atrium Health.
Read More
Insurance Insights: Dr Jason Shafrin Estimates DMD Insurance Value
July 18th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the July 2024 issue of The American Journal of Managed Care® that estimates the insurance value of novel Duchenne muscular dystrophy (DMD) treatment.
Listen
Interstitial Lung Abnormalities in Patients With COPD Linked to Cancer, Heart Failure Risks
October 23rd 2024Interstitial lung abnormalities (ILAs) in patients with chronic obstructive pulmonary disease (COPD) are linked to lower lung adenocarcinoma rates but higher rates of other cancers and heart failure.
Read More
From Polypharmacy to Personalized Care: Dr Nihar Desai Discusses Holistic Cardiovascular Care
May 30th 2024In this episode of Managed Care Cast, Nihar Desai, MD, MPH, cardiologist and vice chief of Cardiology at the Yale School of Medicine, discusses therapies for cardiovascular conditions as they relate to patient adherence, polypharmacy, and health access.
Listen
FIT Completion, Yield Rates in CRC Screening Similar After New Screening Guidelines
October 22nd 2024Patients were found to have similar completion and yield rates for the fecal immunochemical test (FIT) at both 45 years and 50 years, making screening for colorectal cancer (CRC) effective in younger patients.
Read More
Neoadjuvant Chemotherapy Becomes Leading Initial Treatment for Advanced Epithelial Ovarian Cancer
October 22nd 2024By 2021, neoadjuvant chemotherapy followed by interval cytoreductive surgery became the most common initial treatment for patients with advanced epithelial ovarian cancer, overtaking primary cytoreductive surgery.
Read More